REFERENCES
- Zito JM, Caig TJ: Pharmacoepidemiology of psychotic disor-ders. In: Hartzema AG, Porta MS, eds. Pharmacoepidemiol-ogy—An Introduction, 2nd ed. Cincinnati, OH: Harvey Whitney Books; 1991
- Zito JM, Craig TJ, Wanderling, et al.: Pharmacotherapy of the hospitalized young adult schizophrenic patient. Compr Psychiatry 1988; 29:379–386
- Fennig S, Craig TJ, Karant M, et al.: A comparison of facility and research diagnosis in first admission psychotic patients. Am J Psychiatry 1994; 151:1423–1429
- Bromet EJ, Schwartz J, Fennig S, et al.: The epidemiology of psychosis: The Suffolk County Mental Health Project. Schi-zophr Bull 1992; 18:243–255
- Spitzer RL, Williams JBW, Gibbon M, et al.: The Struc-tured Clinical Interview for DSM-III-R (SCID) I: History, rationale, and description. Arch Gen Psychiatry 1992; 49:624–629
- Sernyak MJ, Griffin RA, Johnson RM, et al.: Neuroleptic ex-posure following inpatient treatment of acute mania with lith-ium and neuroleptic. Am J Psychiatry 1994; 151:133–135
- Sernayk MJ, Woods SW: Chronic neuroleptic use in manic-depressive illness. Psychopharm Bull 1993; 29: 375–381
- American Psychiatric Association Practice Guidelines: Practi-cal guidelines for major depressive disorders in adults. Am J Psychiatry 1993; 150(suppl):1–26
- American Psychiatric Association Practice Guidelines for the Treatment of Patients with Bipolar Disorder. Am J Psychiatry 1994; 151(suppl):1–36